The global orthopedic regenerative medicine market is expected to reach USD 5.9 billion by 2030, at a CAGR of 4% during the forecast period 2021 to 2030. The orthopedic regenerative medicine market has grown due to increasing technological advancements, the prevalence of arthritis, and the rise in orthopedic surgeries.